天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
ChemicalBook
TargetMol Chemicals Inc. 企業(yè)の連絡(luò)先情報(bào)
名前:
TargetMol Chemicals Inc.
電話(huà)番號(hào):
-
電子メール:
marketing@targetmol.com
國(guó)籍:
China
ウェブサイト:
https://www.targetmol.cn/
商品の合計(jì)數(shù):
19704
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
製品カタログ
Kallikrein-IN-2
2702983-84-2
C28H25F3N4O4
mGAT-IN-1
2556833-08-8
C28H34ClN3O2S2
VEGFR-2-IN-22
2447587-73-5
C26H24ClFN4O6
BuChE-IN-2
2745118-93-6
C28H20F4N6O3
Lipid-lowering agent-1
2304859-34-3
C26H19ClF3NO6S
IZTZ-1
2636771-45-2
C32H35N7S
HBV-IN-8
2724224-57-9
C21H25ClFN5O5S2
DCN1-UBC12-IN-2
2374827-47-9
C23H20ClN7O3S2
PI3K-IN-27
2742654-38-0
C30H26F2N6O2S
Antibacterial agent 115
2259732-60-8
C35H48N2O3
HBV-IN-19 TFA
2241575-60-8
RAD51-IN-6
2690367-57-6
C27H40N3O5PS
PG 34
1681056-62-1
C28H25N3O5S2
Estrogen receptor antagonist 3
2730011-50-2
C26H29BF6N4O2
PDE5/HDAC-IN-1
2414921-48-3
C27H29BrN4O4
B-Raf IN 6
2648698-34-2
C24H21F3N6O2S2
hCAXII-IN-3
2417232-24-5
C26H20BrN5O3S
ACC1/2-IN-1
2350219-22-4
C34H32N4O4
α-Glycosidase-IN-1
2428389-66-4
C21H19N9O6S2
DPP-4/GPR119 modulator 2
2010927-65-6
C30H40N8O3
RECQL5-IN-1
2718170-45-5
C25H18F6N4O2S
LRRK2-IN-2
2641059-19-8
C23H23Cl2F3N6O2
HIV-1 protease-IN-2
2248124-46-9
C27H34N4O7S
ERα antagonist 1
2762423-09-4
C33H32N2O5S
PAK4-IN-1
2396529-58-9
C26H30ClN7O5
Cap-dependent endonuclease-IN-5
2416258-53-0
C27H21F2N3O4S2
BCR-ABL-IN-4
2669790-59-2
C27H24ClF2N5O4
RORγt agonist 3
2664106-24-3
C34H37N3O3S
Adenylyl cyclase type 2 agonist-1
2414908-52-2
C27H17BrClNO5
RET-IN-19
2484919-71-1
C28H28N6O4S
CYP3A4-IN-1
2771297-34-6
C31H37N5O3S
Multi-kinase-IN-3
2091950-43-3
C33H33N5O3
IRE1α kinase-IN-3
2416223-41-9
C29H32N6O3S
DHODH-IN-22
2450341-75-8
C21H21ClF4N6O5
BLK-IN-1
1431727-00-2
C29H23F3N6O3
EGFR-IN-50
2044508-48-5
C24H26BrN3O4S2
KS100
2408477-54-1
C17H14Br3N3O2S
Omesdafexor
2244440-85-3
C34H43N3O3
XP-524
2344825-52-9
C30H28N6O3S
GLP-1R agonist 10
2762515-25-1
C29H29ClFN5O4
HER2-IN-8
2704630-49-7
C26H25F2N9O3
HDAC-IN-44
2414921-46-1
C26H27BrN4O4
Anticancer agent 76
2448091-11-8
C32H33NO5S
MMP-9-IN-4
2581824-39-5
C28H19F3N4O6
HIV-IN-5
2459929-62-3
C30H24N2O8S
c-Met-IN-13
2377724-93-9
C30H28F2N2O6
HBV-IN-6
2724224-47-7
C23H21ClFN3O5S2
LDC0496
2411874-83-2
C32H35N5O3
IKKβ-IN-1
2410423-31-1
C31H30N4O4S
HER2-IN-7
2387574-01-6
C28H26F3N7O3
Antitumor agent-45
2581082-74-6
C28H17BrFN5O3
Antimycobacterial agent-3
2469881-50-1
C21H15F6N5O4S
HDAC-IN-36
2482992-54-9
C29H39N5O5
Keap1-Nrf2-IN-14
1928782-31-3
C30H29NO8S
Anticancer agent 41
1394077-28-1
C25H18Br2N2O3
RAD51-IN-5
2690367-19-0
C26H38N4O5S2
Multi-kinase-IN-2
2095628-21-8
C34H35N5O3
EGFR-IN-32
2701553-78-6
C31H34N6O3
BACE1-IN-12
2479315-19-8
C29H28Cl2N6O
RORγt inverse agonist 28
2741870-21-1
C23H18Cl2F3NO5S
hCA I-IN-2
2417232-12-1
C26H20BrN5O3S
Anticancer agent 50
2487457-15-6
C30H32N2O4Se
c-Fms-IN-12
2145102-33-4
C30H32N6O6
A3AR antagonist 1
2413257-74-4
C32H24N4O4S
ATR-IN-5
2601571-19-9
C27H32F3N9O
CCT373567
2378853-67-7
C26H29ClF2N6O3
SAP2-IN-1
2512847-37-7
C34H29NO7
CDK9/10/GSK3β-IN-1
2423045-06-9
C29H24ClN3O4S
Axl-IN-12
2758062-17-6
C30H30N8O3
Lp-PLA2-IN-9
2637485-12-0
C25H19ClF5N3O4
GLP-1R agonist 8
2736446-82-3
C33H32N4O5
hGGPPS-IN-2
2241547-82-8
C20H18FN5O7P2S
Cap-dependent endonuclease-IN-17
2649362-71-8
C24H20F2N3O7PS
Antitubercular agent-20
2413124-92-0
C25H22F6N4O3S
Tubulin polymerization-IN-7
1394017-46-9
C28H24N4O6S
VEGFR-2-IN-28
2447597-39-7
C26H17N7O7
ALK5-IN-9
2489611-06-3
C29H35F3N6O3
Cap-dependent endonuclease-IN-14
2740486-73-9
C30H23FN2O6S
CYP3A4-IN-2
2562383-94-0
C33H38N4O3S
Anticancer agent 67
2691895-66-4
C26H24F2N6O2S2
CYP3A4-IN-3
2562384-19-2
C34H39N3O3S
Antitubercular agent-19
2248171-05-1
C24H20F6N4O3S
WNY1613
2650546-39-5
C29H35N9O3
EGFR-IN-31
2701563-03-1
C32H36FN7O2
AChE-IN-20
2428389-65-3
C22H20N8O6S2
LXRβ agonist-3
2413308-63-9
C30H33N3O6S
Thi-DPPY
2307699-34-7
C28H28ClN5O4S
AChE-IN-12
2764664-52-8
C33H41NO7
Anti-Trypanosoma cruzi agent-3
2397639-23-3
C29H29N3O6S
MAT2A-IN-1
2667053-18-9
C29H28F2N6O4
SARS-CoV-2-IN-19
2244991-17-9
C33H38N2O6
PRMT5-IN-18
2756849-68-8
C32H42N4O4
Axl-IN-5
2642224-24-4
C31H35N5O2S
Sitagliptin fenilalanil
1339955-03-1
C25H24F6N6O2
PLK1-IN-4
2622273-55-4
C24H25F3N6O4S
EZH2-IN-11
2387402-80-2
C28H36ClN3O5S
Anticancer agent 61
2413148-53-3
C22H22N3Na2O8PS
RET-IN-17
1885880-08-9
C27H28F4N4O4
DNMT3A-IN-1
1403598-56-0
C30H38N6O4
Axl-IN-8
2231424-62-5
C31H29FN6O3
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
Copyright 2017 ? ChemicalBook. All rights reserved